Electrophysiological monitoring of dopaminergic therapy using short-latency median nerve somatosensory evoked potentials (SEPS) in Parkinson's disease

Author： Mauguiegrave re F.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 234-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evoked potentials monitoring in Parkinson's disease therapy

By Stanzione P.   Pierantozzi M.   Semprini R.   Traversa R.   Bernardi G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 233-234

Elsevier

Access to resources Recommend Favorite

Dopaminergic substitution in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Non-dopaminergic drug treatment of Parkinson’s disease

By Müller T.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 557-572

Informa Healthcare

Access to resources Recommend Favorite

Existing dopaminergic therapies for Parkinson’s disease

By Dutta PhD Aloke K   Le MD   PhD Weidong  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1613-1625

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Nerve Growth Factors in Parkinson's Disease

By Collier T.J.   Sortwell C.E.  

Drugs & Aging, Vol. 14, Iss. 4, 1999-04 ,pp. : 261-287

Adis International

Access to resources Recommend Favorite